Alfred D. Kingsley - Chairman, Director at Lineage Cell Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chairman, Director
Stock Symbol
LCTX on NYSE
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Alfred D. Kingsley since 4/21/2024

Holdings reported by Alfred D. Kingsley for Lineage Cell Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares, no par value 5.43M $5.92M $1.09 Dec 1, 2022 Direct
Common Shares, no par value 1.04M $1.14M $1.09 Dec 31, 2022 By Corporation
Common Shares, no par value 375K $409K $1.09 Dec 31, 2022 By LP
Stock Option (Right to Buy) 50K Jul 1, 2023 Direct Common Shares

Transactions reported by Alfred D. Kingsley for Lineage Cell Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.